Drug details

Sesquient (fosphenytoin sodium injection)

type of Anticonvulsants, Hydantoins

Sesquient (fosphenytoin sodium) is an anticonvulsant used to treat generalized tonic-clonic status epilepticus in adult patients and to prevent and treat seizures occurring during neurosurgery in adult patients and for short-term substitution for oral phenytoin in patients 2 years of age and older.

This drug may have the following side effects:

• itching,
• dizziness,
• loss of coordination,
• sleepiness,
• low blood pressure
• ringing in the ears,
• nausea, and
• Involuntary eye movements (nystagmus),
• vomiting (in children),

The following drugs are related to Sesquient, either as a replacement or used together:

• Diamox Sequels (acetazolamide xr)
• Aptiom (eslicarbazepine acetate tablets)
• Banzel (rufinamide tablets)
• Tegretol (carbamazepine)
• Zarontin (ethosuximide)
• Zarontin Oral Solution (ethosuximide oral solution)
• Fycompa (perampanel tablets, for oral use)
• Keppra (levetiracetam)
• Keppra Injection (levetiracetam)
• Keppra XR (levetiracetam extended-release tablets)
• Vimpat (lacosamide tablet and injection)
• Lamictal (lamotrigine)
• Lamictal XR (lamotrigine extended-release tablets)
• Mysoline (primidone)
• Trileptal (oxcarbazepine)
• Sabril (vigabatrin oral solution)